Description
There has been an increasing standard of living in the Middle East and Africa due to higher national income. This has contributed to a higher incidence of heart disease – high blood pressure, high cholesterol and high blood sugar. In fact, the Middle East/Africa region is one of the higher areas for heart disease which has prompted more individuals being admitted to the hospital. This has caused an uptick in the demand for diagnostic testing devices and medical devices.
This report provides an overview of developments in the in vitro diagnostics industry in the Middle East and Africa. The countries covered are
- Egypt
- Iran
- Iraq
- Israel
- Jordan
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates (UAE)
- Other Mideast (Bahrain, Cyprus, Gaza Strip, Kuwait, Lebanon, Oman, Qatar, Syria, West Bank, Yemen)
- Other Africa (Algeria, Congo, Sudan, Libya, Chad, Niger, Angola, Mali, Ethiopia, etc.)
Scope
The Middle East, Africa market for in vitro diagnostics is provided in U.S. dollars for the years 2021 – 2026.
The report covers six segments of the IVD market in the Middle East:
- Clinical Chemistry
- Immunoassay
- Microbiology
- Point of Care (POC)
- Histology – traditional stains
- Other (includes nucleic acid assays, blood bank ABO, sequencing, prenatal tests and other areas not covered specifically in the above segments)
Table of Contents
Chapter 1: Executive Summary
Overview
Scope and Methodology
Size and Growth of the Market
- Figure 1-1: IVD in the Middle East, Africa, 2021-2026 CAGR 2.2% ($ millions)
Chapter 2: Middle East and Africa: Regional Overview
Overview
Regional Market Overview
- Table 2-1: Mideast/Africa In Vitro Diagnostic Sales by Country, 2021-2026 ($ millions) (Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates, Other Mideast, South Africa, Other Africa, Total)
- Figure 2-1: Mideast/Africa In Vitro Diagnostic Sales by Country, 2021-2026 – Eight Countries Generate nearly 75% Market Value (Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates, Other Mideast, South Africa, Other Africa)
Population
- Table 2-2: Elderly Dependency Ratio in Middle East and Other Select Countries, 2010 and 2050
- Table 2-3: World Population: Major Countries in the Mideast and Africa Region (Egypt, Iraq, Iran, Israel, Jordan, Saudi Arabia, South Africa, Turkey, United Arab Emirates), 2010-2030 (million persons)
- Figure 2-2: Middle East and Africa Region, Population Density by Country, 2022 Est.
Major Diseases Affecting the Middle Eastern / African Population
Cardiovascular Diseases
Cancer
- Table: 2-4: The Most Frequent Cancers by Country of Middle East and Africa (%) As Reported by National Cancer Registry Programs, 2020
Diabetes
- Table 2-5: People Living with Diabetes in Middle East/Africa Region and Projections 2045 (millions of people)
Middle Eastern Respiratory Syndrome (MERS)
MERS Situation Update, February 2022
- Table 2-6: Epidemiological Characteristics of MERS Cases Reported Globally, (Dec 2017 – May 2018 through Sept 2021 – Feb 2022)
Market Response to MERS
SARS-CoV-2 (COVID-19)
COVID-19 Situation in MEA
Market Response to COVID-19
- Table 2-7: Selected MEA COVID-19 Statistics – Total Cases, Total Deaths, New Cases Last 7 Days, May 20, 2022
- Figure 2-3: Selected MEA COVID-19 Statistics – Total Cases, Total Deaths, New Cases Last 7 Days , May 20, 2022
Chapter 3: Egypt IVD Market
Overview
Market Summary
- Table 3-1: Egypt In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 3-1: Egypt In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 3-2: Egypt – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 3-2: POC Market Distribution (POC Glucose, POC Other) for Egypt, 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 3-3: Egypt IVD Market: Strengths and Weaknesses
COVID-19 Pandemic Situation
- Table 3-3: COVID-19 Pandemic Situation: Egypt, updated May 20, 2022
- Figure 3-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
Market Participant Activity
- Figure 3-5: Selected IVD-Related Participant Activity: Egypt
Chapter 4: Iran IVD Market
Overview
- Figure 4-1: Iran’s Crude Oil Production, 1975 – 2020 (millions of barrels per day)
Market Summary
- Table 4-1: Iran In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 4-2: Iran In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 4-2: Iran – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 4-3: POC Market Distribution (POC Glucose, POC Other) for Iran, 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 4-4: Iran IVD Market: Strengths and Weaknesses
COVID-19 Pandemic Situation
- Table 4-3: COVID-19 Pandemic Situation: Iran, updated May 20, 2022
- Figure 4-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
Chapter 5: Iraq IVD Market
Overview
- Figure 5-1: Iraq’s Production and Consumption of Petroleum and Other Liquids, 1990 – 2020 (millions of barrels per day)
Market Summary
- Table 5-1: Iraq In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 5-2: Iraq In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 5-2: Iraq – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 5-3: POC Market Distribution (POC Glucose, POC Other) Percent for 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 5-4: Iraq IVD Market: Strengths and Weaknesses
COVID-19 Pandemic Situation
- Table 5-3: COVID-19 Pandemic Situation: Iraq, updated May 20, 2022
- Figure 5-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
Market Participant Activity
- Figure 5-6: Selected IVD-Related Participant Activity: Iraq
Chapter 6: Israel IVD Market
Overview
Market Summary
- Table 6-1: Israel In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 6-1: Israel In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 6-2: Israel – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 6-2: POC Market Distribution (POC Glucose, POC Other) for Israel, 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 6-3: Israel IVD Market: Strengths and Weaknesses
COVID-19 Pandemic Situation
- Table 6-3: COVID-19 Pandemic Situation: Israel, updated May 20, 2022
- Figure 6-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
Market Participant Activity
- Figure 6-5: Selected IVD-Related Participant Activity: Israel
Chapter 7: Jordan IVD Market
Overview
Market Summary
- Table 7-1: Jordan In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 7-1: Jordan In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 7-2: Jordan – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 7-2: POC Market Distribution (POC Glucose, POC Other) for Jordan, 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 7-3: Jordan IVD Market: Strengths and Weaknesses
COVID-19 Pandemic Situation
- Table 7-3: COVID-19 Pandemic Situation: Jordan, updated May 20, 2022
- Figure 7-4: COVID-19 Pandemic Confirmed Case Pattern, through May 15, 2022
Chapter 8: Saudi Arabia IVD Market
Overview
- Figure 8-1: Saudi Arabia Crude Oil Production, Annual Average Per Day (millions of barrels), 1995-2020
Market Summary
- Table 8-1: Saudi Arabia In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 8-2: Saudi Arabia In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 8-2: Saudi Arabia – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 8-3: POC Market Distribution (POC Glucose, POC Other) for Saudi Arabia, 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 8-4: Saudi Arabia IVD Market: Strengths and Weaknesses
COVID-19 Pandemic Situation
- Table 8-3: COVID-19 Pandemic Situation: Saudi Arabia, updated May 20, 2022
- Figure 8-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
Market Participant Activity
- Figure 8-6: Selected IVD-Related Participant Activity: Saudi Arabia
Chapter 9: South Africa IVD Market
Overview
Market Summary
- Table 9-1: South Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 9-1: South Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 9-2: South Africa – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 9-2: POC Market Distribution (POC Glucose, POC Other) for South Africa, 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 9-3: South Africa IVD Market: Strengths and Weaknesses
Ebola Outbreaks
- Figure 9-4: DRC Ebola Virus Disease Outbreak: Equateur Province, 2022 (Provinces and Health Zones)
- Table 9-3: Ebola Virus Outbreaks by Species and Size, 1976 – 2021
COVID-19 Pandemic Situation
- Table 9-4: COVID-19 Pandemic Situation: South Africa, updated May 20, 2022
- Figure 9-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
Market Participant Activity
- Figure 9-6: Selected IVD-Related Participant Activity: South Africa
Chapter 10: Turkey IVD Market
Overview
Market Summary
- Table 10-1: Turkey In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 10-1: Turkey In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 10-2: Turkey – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 10-2: POC Market Distribution (POC Glucose, POC Other) for Turkey, 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 10-3: Turkey IVD Market: Strengths and Weaknesses
COVID-19 Pandemic Situation
- Table 10-3: COVID-19 Pandemic Situation: Turkey, updated May 20, 2022
- Figure10-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
Market Participant Activity
- Figure 10-5: Selected IVD-Related Participant Activity: Turkey
Chapter 11: United Arab Emirates (UAE) IVD Market
Overview
- Figure 11-1: UAE’s Production and Consumption of Petroleum and Other Liquids, 2008-2018 (millions of barrels per day)
Market Summary
- Table 11-1: United Arab Emirates In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Figure 11-2: United Arab Emirates In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table 11-2: United Arab Emirates – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
- Figure 11-:3 POC Market Distribution (POC Glucose, POC Other) for United Arab Emirates, 2021 and 2026
Market Strengths and Weaknesses (Drivers and Inhibitors)
- Figure 11-4: United Arab Emirates IVD Market: Strengths and Weaknesses
COVID-19 Pandemic Situation
- Table 11-3: COVID-19 Pandemic Situation: United Arab Emirates, updated May 20, 2022
- Figure 11-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
Market Participant Activity
- Figure 11-6: Selected IVD-Related Participant Activity: United Arab Emirates
Chapter 12: Total Mideast & Africa IVD Market
Overview
Summary
- Table 12-1: Mideast/Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
Clinical Chemistry Market
Immunoassay Market
Microbiology Market
Point-of-Care Market
Histology Market
